Hunan Kangyuan Pharmaceutical is a wholly-owned subsidiary of Chongqing Lummy Pharmaceutical Co., Ltd. It currently has production bases in Liuyang and Yiyang respectively, and a marketing center in Changsha, with approximately 500 employees.
Hunan Kangyuan Pharmaceutical Co., Ltd. was established in September 2000, specializing in the production of soft bag infusion and plastic bottle infusion. In January 2004, it acquired the former Yiyang Biyun Pharmaceutical Factory. It now has production bases in *Liuyang Economic and Technological Development Zone and Hunan Yiyang Longling Industrial Park that meet GMP requirements, and has set up a marketing center in Changsha. The Liuyang plant covers an area of more than 60,000 square meters, with a current building area of 32,000 square meters and a green area of more than 28,000 square meters.
The company has established a strict quality system to manage the entire process of production, sales and after-sales service in an all-round way. In terms of product technical performance, it has reached the advanced level of the same industry in China. Its products are distributed in more than 1,200 pharmaceutical companies and hospitals in more than 20 provinces across the country. The company is a high-tech enterprise in Hunan Province, and its trademark is a * trademark of Hunan Province. The company has been rated as one of the top ten pharmaceutical enterprises in Hunan Province, a quality credit A-level enterprise in Hunan Province, an enterprise with tax revenue of over ten million yuan, and won the second prize of Liuyang Science and Technology Invention Award, etc.
Hunan Kangyuan Pharmaceutical Co., Ltd. currently has 54 drug approval numbers, mainly for ordinary glucose and sodium chloride infusions. Among them, the soft bag sodium bicarbonate injection has obtained a national patent for its production process and is an exclusive patented variety. It has unique features in the innovation of packaging forms and the selection of pharmaceutical packaging materials. In October 2010, Chongqing Lummy Pharmaceutical Co., Ltd. acquired 100% equity of Hunan Kangyuan Pharmaceutical Co., Ltd. Through the expansion of production scale and the improvement of personnel quality, it has rationalized the market and occupied more market share. The company's current annual operating income is about 300 million yuan.
Hunan Kangyuan Pharmaceutical Co., Ltd. will be the pride of Hunan people and will also become a banner of soft bag infusion. The company will follow the purpose of "seeking truth, innovating, and serving the public" and strive to stand forever in the forest of Chinese national medicine.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows